Bell Medical Solutions

fda
MedTech

Xavant brings neuromodulation pain device to U.S.

The move follows the receipt of 510(k) clearance from the FDA, which deemed the device similar enough to Bioinduction’s Acticare to come to market.
Nick Paul Taylor Aug 2, 2017 11:06am